Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Open
Phase 2
This trial is looking at adding a new drug called pumitamig to docetaxel chemotherapy. It is for people whose non small cell lung cancer is getting worse.
It is for people:
whose cancer has spread to another part of the body
who have already had a combination of chemotherapy and immunotherapy for
Recruitment start: 1 June 2025
Recruitment end: 1 October 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Shaw
BioNTech SE
Last reviewed: 10 Dec 2025
CRUK internal database number: 20097
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
